CBG oil is a hemp-derived supplement containing cannabigerol, a non-intoxicating compound from the cannabis plant. Often called the “mother cannabinoid,” CBG is the chemical precursor that the plant converts into better-known cannabinoids like THC and CBD. Because the plant naturally transforms most of its CBG into other compounds as it matures, CBG is present in very small quantities in harvested cannabis, making it rarer and typically more expensive than CBD oil. It won’t get you high, and early research suggests it has its own distinct set of potential health benefits.
Why CBG Is Called the Mother Cannabinoid
Every cannabinoid the cannabis plant produces starts as cannabigerolic acid, or CBGA, the acidic form of CBG. CBGA is the common building block that specialized enzymes in the plant convert into the precursors of THC, CBD, and CBC (cannabichromene). By the time the plant reaches full maturity, most of its CBGA has been used up in this conversion process. That’s why young cannabis plants contain more CBG than mature ones, and why breeders have developed specific high-CBG hemp strains harvested early to capture more of this compound before it transforms.
CBG oil is made by extracting cannabigerol from these high-CBG hemp plants and suspending it in a carrier oil, just like CBD oil. You’ll find it sold as a standalone product or blended with CBD in combination formulas.
How CBG Works in the Body
Like CBD, CBG interacts with the body’s endocannabinoid system, but the two compounds behave differently at a molecular level. CBG binds to both of the main cannabinoid receptors (CB1 and CB2) with low micromolar affinity. Lab measurements show CBG actually binds to CB2 receptors with slightly greater affinity than CBD does. Importantly, CBG does not directly activate the CB1 receptors in the brain the way THC does, which is why it produces no intoxicating effects.
Beyond cannabinoid receptors, CBG appears to influence several other biological targets, including receptors involved in pain signaling, inflammation, and oxidative stress. This multi-target activity is what makes researchers interested in its therapeutic potential, even though most findings are still from animal and lab studies rather than large human trials.
Potential Benefits Under Investigation
Gut Inflammation
One of the more promising areas of CBG research involves inflammatory bowel disease. In a mouse model of colitis, daily treatment with a high-CBG hemp extract dramatically reduced disease severity. The treated mice had less colon tissue damage, longer colons (a sign of reduced inflammation), and lower disease activity scores compared to untreated mice. Researchers also found that CBG treatment shifted the gut microbiome in potentially beneficial ways and normalized several metabolic pathways tied to inflammation. While this doesn’t prove CBG will work the same way in humans with Crohn’s disease or ulcerative colitis, it points to a meaningful biological effect worth further study.
Antibacterial Activity
CBG has shown surprising potency against antibiotic-resistant bacteria. Testing of the five major cannabinoids against six clinically relevant strains of MRSA (methicillin-resistant Staphylococcus aureus) found that all of them, CBG included, killed these bacteria at very low concentrations, in the range of 0.5 to 2 micrograms per milliliter. That’s a level of potency comparable to some conventional antibiotics. This doesn’t mean CBG oil can treat a staph infection, but it has attracted serious interest from researchers looking for new weapons against drug-resistant bacteria.
Neuroprotection
A 2015 study in mice modeled Huntington’s disease, a neurodegenerative condition that destroys motor control and cognitive function. CBG improved motor deficits and preserved neurons in the brain region most affected by the disease. It also reduced inflammation markers in the brain, restored antioxidant defenses, and partially normalized the expression of genes linked to Huntington’s progression. In a genetic mouse model of the disease, CBG treatment boosted levels of two key growth factors that support neuron survival: BDNF and IGF-1. The treated mice also showed fewer clumps of the mutant protein that drives Huntington’s damage.
Eye Pressure
CBG may help lower intraocular pressure, the key risk factor in glaucoma. Research suggests it works by dilating the drainage canal in the eye (called Schlemm’s canal), which allows fluid to flow out more easily. This is a different mechanism than THC, which also lowers eye pressure but acts on the muscle that controls fluid production. The data on CBG specifically for glaucoma is still limited, and the pressure-lowering effects of cannabinoids in general tend to be short-lived, lasting only a few hours per dose.
How CBG Differs From CBD
CBG and CBD share some traits: both are non-intoxicating, both interact with the endocannabinoid system, and both show anti-inflammatory properties in lab settings. But they aren’t interchangeable. CBG binds more readily to cannabinoid receptors than CBD does, which gives it a somewhat different pharmacological profile. Some users describe CBG as more energizing or focus-enhancing compared to CBD, which people more commonly associate with relaxation, though this distinction hasn’t been rigorously tested in clinical trials.
Some users also report that CBG improves their sleep, though this hasn’t been confirmed by controlled studies either. Because the two compounds work through partially different mechanisms, combination products containing both CBG and CBD have become popular, based on the idea that they may complement each other.
Dosage, Side Effects, and Practical Considerations
There are no established clinical dosing guidelines for CBG oil. Most products on the market contain between 500 and 2,000 milligrams of CBG per bottle, with suggested serving sizes ranging from around 10 to 50 milligrams per dose. The general approach most people take is starting with a low dose and gradually increasing until they notice effects.
Side effects appear to be mild based on available evidence. CBG does not produce the intoxication associated with THC because it doesn’t activate the brain receptors responsible for that effect. Reported side effects are similar to those seen with CBD: dry mouth, mild drowsiness, and changes in appetite. Because CBG products are sold as supplements rather than pharmaceuticals, quality varies significantly between brands. Look for products that provide third-party lab testing (often called a certificate of analysis) showing the actual CBG content and confirming the absence of contaminants like heavy metals, pesticides, and residual solvents.
CBG oil’s higher price compared to CBD oil reflects the difficulty of producing it. Because the cannabis plant converts most of its CBG into other cannabinoids as it grows, extracting meaningful amounts requires either harvesting plants very early or using specially bred high-CBG cultivars. Both approaches yield less raw material than standard CBD hemp production, which drives costs up. As more high-CBG strains become commercially available, prices have been gradually coming down.